In people with type 1 diabetes (T1D), the immune system shuts down the body's ability to make the hormone insulin, ...

Evidence shows that research designed with communities — through shared governance, fair compensation, and mutual ...

J. Craig Venter, a scientist and entrepreneur who raced to decode the human genome, died on Wednesday in San Diego. He was 79 ...

Detailed price information for Relay Therapeutics Inc (RLAY-Q) from The Globe and Mail including charting and trades.

Mortality disparities among people of different genetic ancestries are increasing, highlighting the need for more diverse ...

A squad of new AI algorithms called GAME could help astrophysicists take a more accurate reading of the universe’s behavior, ...

The FDA has granted accelerated approval to lunsotogene parvec-cwha (Otarmeni), an adeno-associated virus (AAV) vector–based ...

T-cell therapy is one of oncology's most powerful ideas: Harvest a cancer patient's own immune cells, genetically engineer ...

Serif Biomedicines has emerged from stealth mode to continue developing “modified DNA,” a new class of therapeutics designed ...

Shannon Blajeski explains how people with serious mental illness can live independently and not be stuck in poverty.

Is RYTM a good stock to buy? We came across a bearish thesis on Rhythm Pharmaceuticals, Inc. on BioEquity Watch’s Substack. In this article, we will summarize the bears’ thesis on RYTM. Rhythm ...

For the first time in decades, the number of nuclear warheads is on the rise. Nuclear testing is back on the table and global ...